Botox Shows Promise for Dementia-Related Paratonia, Costs and Approvals Lag
TL;DR
Canadian researchers report that botulinum toxin injections can ease paratonia in advanced dementia, reducing pain and easing caregiving for more than 100 patients, but the treatment is not Health Canada-approved for paratonia and costs around $12,000 per year, limiting access and highlighting the need for larger trials.
- Experimental treatment could ease ‘misunderstood’ dementia symptom - National Global News
- Baycrest Research Highlights Overlooked Condition Affecting People with Advanced Dementia Newswire Canada
- Paratonia remains underrecognized in advanced dementia care, research finds Benefits and Pensions Monitor
- Experimental treatment could ease ‘misunderstood’ dementia symptom unpublished.ca
- Patients suffering from dementia symptom, paratonia, may find relief in Botox Yahoo News Canada
Want the full story? Read the original reporting
Read on Global News